• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    NewLink Genetics Corporation (NLNK)

    -NasdaqGM
    39.40 Up 0.16(0.41%) Jan 23, 4:00PM EST
    Add to Portfolio
    Prev Close:39.24
    Open:39.04
    Bid:N/A
    Ask:40.30 x 200
    1y Target Est:45.40
    Beta:0.25
    Next Earnings Date:N/A
    Day's Range:38.99 - 40.33
    52wk Range:17.32 - 53.48
    Volume:260,931
    Avg Vol (3m):711,664
    Market Cap:1.10B
    P/E (ttm):N/A
    EPS (ttm):-1.17
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NLNKUp 0.41%1.10B
    LLYDown 0.46%77.15B
    TEVAUp 2.38%51.19B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):301.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.74
    Quarterly EPS Est (Dec-14) :-0.68
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback